Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

The Mechanobiology of the Actin Cytoskeleton in Stem Cells during Differentiation and Interaction with Biomaterials.

Ambriz X, de Lanerolle P, Ambrosio JR.

Stem Cells Int. 2018 Oct 8;2018:2891957. doi: 10.1155/2018/2891957. eCollection 2018. Review.

2.

Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin.

Serebryannyy LA, Yemelyanov A, Gottardi CJ, de Lanerolle P.

J Cell Sci. 2017 May 15;130(10):1717-1729. doi: 10.1242/jcs.199893. Epub 2017 Mar 27.

3.

The Effects of Disease Models of Nuclear Actin Polymerization on the Nucleus.

Serebryannyy LA, Yuen M, Parilla M, Cooper ST, de Lanerolle P.

Front Physiol. 2016 Oct 7;7:454. eCollection 2016.

4.

Persistent nuclear actin filaments inhibit transcription by RNA polymerase II.

Serebryannyy LA, Parilla M, Annibale P, Cruz CM, Laster K, Gratton E, Kudryashov D, Kosak ST, Gottardi CJ, de Lanerolle P.

J Cell Sci. 2016 Sep 15;129(18):3412-25. doi: 10.1242/jcs.195867. Epub 2016 Aug 2.

5.

A Role for Nuclear Actin in HDAC 1 and 2 Regulation.

Serebryannyy LA, Cruz CM, de Lanerolle P.

Sci Rep. 2016 Jun 27;6:28460. doi: 10.1038/srep28460.

6.

Nuclear F-actin enhances the transcriptional activity of β-catenin by increasing its nuclear localization and binding to chromatin.

Yamazaki S, Yamamoto K, de Lanerolle P, Harata M.

Histochem Cell Biol. 2016 Apr;145(4):389-99. doi: 10.1007/s00418-016-1416-9. Epub 2016 Feb 22.

PMID:
26900020
7.

Nuclear actin and myosins in adenovirus infection.

Fuchsova B, Serebryannyy LA, de Lanerolle P.

Exp Cell Res. 2015 Nov 1;338(2):170-82. doi: 10.1016/j.yexcr.2015.07.025. Epub 2015 Jul 27.

8.

Corrigendum: Nuclear actin and myosins: Life without filaments.

de Lanerolle P, Serebryannyy L.

Nat Cell Biol. 2015 Jun;17(6):827. doi: 10.1038/ncb3182. No abstract available.

PMID:
26022919
9.

Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells.

Yu HJ, Serebryannyy LA, Fry M, Greene M, Chernaya O, Hu WY, Chew TL, Mahmud N, Kadkol SS, Glover S, Prins G, Strakova Z, de Lanerolle P.

PLoS One. 2013 Nov 4;8(11):e79776. doi: 10.1371/journal.pone.0079776. eCollection 2013.

10.

Nuclear actin and myosins at a glance.

de Lanerolle P.

J Cell Sci. 2012 Nov 1;125(Pt 21):4945-9. doi: 10.1242/jcs.099754. Review. No abstract available.

11.

MLCK regulates Schwann cell cytoskeletal organization, differentiation and myelination.

Leitman EM, Tewari A, Horn M, Urbanski M, Damanakis E, Einheber S, Salzer JL, de Lanerolle P, Melendez-Vasquez CV.

J Cell Sci. 2011 Nov 15;124(Pt 22):3784-96. doi: 10.1242/jcs.080200. Epub 2011 Nov 18.

12.

Nuclear actin and myosins: life without filaments.

de Lanerolle P, Serebryannyy L.

Nat Cell Biol. 2011 Nov 2;13(11):1282-8. doi: 10.1038/ncb2364. Review. Erratum in: Nat Cell Biol. 2015 Jun;17(6):827.

PMID:
22048410
13.

VEGFR2 translocates to the nucleus to regulate its own transcription.

Domingues I, Rino J, Demmers JA, de Lanerolle P, Santos SC.

PLoS One. 2011;6(9):e25668. doi: 10.1371/journal.pone.0025668. Epub 2011 Sep 28.

14.

Herpesviral replication compartments move and coalesce at nuclear speckles to enhance export of viral late mRNA.

Chang L, Godinez WJ, Kim IH, Tektonidis M, de Lanerolle P, Eils R, Rohr K, Knipe DM.

Proc Natl Acad Sci U S A. 2011 May 24;108(21):E136-44. doi: 10.1073/pnas.1103411108. Epub 2011 May 9.

15.

Spatiotemporal organization, regulation, and functions of tractions during neutrophil chemotaxis.

Shin ME, He Y, Li D, Na S, Chowdhury F, Poh YC, Collin O, Su P, de Lanerolle P, Schwartz MA, Wang N, Wang F.

Blood. 2010 Oct 28;116(17):3297-310. doi: 10.1182/blood-2009-12-260851. Epub 2010 Jul 8.

16.

Identification of FBXO25-interacting proteins using an integrated proteomics approach.

Teixeira FR, Yokoo S, Gartner CA, Manfiolli AO, Baqui MM, Assmann EM, Maragno AL, Yu H, de Lanerolle P, Kobarg J, Gygi SP, Gomes MD.

Proteomics. 2010 Aug;10(15):2746-57. doi: 10.1002/pmic.200900419.

17.

SUMOylation of nuclear actin.

Hofmann WA, Arduini A, Nicol SM, Camacho CJ, Lessard JL, Fuller-Pace FV, de Lanerolle P.

J Cell Biol. 2009 Jul 27;186(2):193-200. doi: 10.1083/jcb.200905016.

18.

Manipulating actin dynamics affects human in vitro decidualization.

Ihnatovych I, Livak M, Reed J, de Lanerolle P, Strakova Z.

Biol Reprod. 2009 Jul;81(1):222-30. doi: 10.1095/biolreprod.108.074666. Epub 2009 Apr 1.

19.

Ancient animal ancestry for nuclear myosin.

Hofmann WA, Richards TA, de Lanerolle P.

J Cell Sci. 2009 Mar 1;122(Pt 5):636-43. doi: 10.1242/jcs.030205.

20.

Regulation of myosin light chain kinase expression by angiotensin II in hypertension.

Han YJ, Hu WY, Piano M, de Lanerolle P.

Am J Hypertens. 2008 Aug;21(8):860-5. doi: 10.1038/ajh.2008.199. Epub 2008 May 29.

PMID:
18511912
21.
22.

Increased phosphorylation of myosin light chain prevents in vitro decidualization.

Ihnatovych I, Hu W, Martin JL, Fazleabas AT, de Lanerolle P, Strakova Z.

Endocrinology. 2007 Jul;148(7):3176-84. Epub 2007 Apr 5.

PMID:
17412815
23.

Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats.

Hu WY, Han YJ, Gu LZ, Piano M, de Lanerolle P.

Am J Hypertens. 2007 Jan;20(1):53-61.

PMID:
17198912
24.

Nuclear myosin I is necessary for the formation of the first phosphodiester bond during transcription initiation by RNA polymerase II.

Hofmann WA, Vargas GM, Ramchandran R, Stojiljkovic L, Goodrich JA, de Lanerolle P.

J Cell Biochem. 2006 Nov 1;99(4):1001-9.

PMID:
16960872
25.

From transcription to transport: emerging roles for nuclear myosin I.

Hofmann WA, Johnson T, Klapczynski M, Fan JL, de Lanerolle P.

Biochem Cell Biol. 2006 Aug;84(4):418-26. Review.

PMID:
16936815
26.

Increased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoter.

Han YJ, Hu WY, Chernaya O, Antic N, Gu L, Gupta M, Piano M, de Lanerolle P.

Mol Biol Cell. 2006 Sep;17(9):4039-50. Epub 2006 Jul 5.

27.

Long-range directional movement of an interphase chromosome site.

Chuang CH, Carpenter AE, Fuchsova B, Johnson T, de Lanerolle P, Belmont AS.

Curr Biol. 2006 Apr 18;16(8):825-31.

28.

Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells.

Gu LZ, Hu WY, Antic N, Mehta R, Turner JR, de Lanerolle P.

Eur J Cancer. 2006 May;42(7):948-57. Epub 2006 Mar 30.

PMID:
16574402
29.

Nuclear actin: to polymerize or not to polymerize.

Hofmann WA, de Lanerolle P.

J Cell Biol. 2006 Feb 13;172(4):495-6. Review.

30.

Actin and myosin I in the nucleus: what next?

de Lanerolle P, Johnson T, Hofmann WA.

Nat Struct Mol Biol. 2005 Sep;12(9):742-6. Review.

PMID:
16142228
31.

Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo.

Fazal F, Gu L, Ihnatovych I, Han Y, Hu W, Antic N, Carreira F, Blomquist JF, Hope TJ, Ucker DS, de Lanerolle P.

Mol Cell Biol. 2005 Jul;25(14):6259-66.

32.

Recruiters and academia. Top 10 tips for success in graduate school.

de Lanerolle P.

Nature. 2005 Jan 27;433(7024):442. No abstract available.

PMID:
15674299
33.

Nuclear actin and myosin I are required for RNA polymerase I transcription.

Philimonenko VV, Zhao J, Iben S, Dingová H, Kyselá K, Kahle M, Zentgraf H, Hofmann WA, de Lanerolle P, Hozák P, Grummt I.

Nat Cell Biol. 2004 Dec;6(12):1165-72. Epub 2004 Nov 21.

34.

Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II.

Hofmann WA, Stojiljkovic L, Fuchsova B, Vargas GM, Mavrommatis E, Philimonenko V, Kysela K, Goodrich JA, Lessard JL, Hope TJ, Hozak P, de Lanerolle P.

Nat Cell Biol. 2004 Nov;6(11):1094-101. Epub 2004 Oct 24.

PMID:
15502823
35.

Non-muscle myosin II and myosin light chain kinase are downstream targets for vasopressin signaling in the renal collecting duct.

Chou CL, Christensen BM, Frische S, Vorum H, Desai RA, Hoffert JD, de Lanerolle P, Nielsen S, Knepper MA.

J Biol Chem. 2004 Nov 19;279(47):49026-35. Epub 2004 Aug 30.

36.

Regulation of smooth muscle contraction by calcium, monomeric GTPases of the Rho subfamily and their effector kinases.

Pfitzer G, Wirth A, Lucius C, Brkic-Koric D, Manser E, de Lanerolle P, Arner A.

Adv Exp Med Biol. 2003;538:89-99; discussion 99. No abstract available.

PMID:
15098657
37.

Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1.

Wirth A, Schroeter M, Kock-Hauser C, Manser E, Chalovich JM, De Lanerolle P, Pfitzer G.

J Physiol. 2003 Jun 1;549(Pt 2):489-500. Epub 2003 Apr 11.

38.

Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation.

Nobe H, Nobe K, Fazal F, De Lanerolle P, Paul RJ.

Am J Physiol Cell Physiol. 2003 Mar;284(3):C599-606. Epub 2002 Oct 3.

39.

Cytoskeletal proteins and gene regulation: form, function, and signal transduction in the nucleus.

de Lanerolle P, Cole AB.

Sci STKE. 2002 Jul 2;2002(139):pe30. Review.

PMID:
12096216
40.

Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage.

Yuan SY, Wu MH, Ustinova EE, Guo M, Tinsley JH, De Lanerolle P, Xu W.

Circ Res. 2002 Jun 14;90(11):1214-21.

PMID:
12065325
41.

Myosin-I nomenclature.

Gillespie PG, Albanesi JP, Bahler M, Bement WM, Berg JS, Burgess DR, Burnside B, Cheney RE, Corey DP, Coudrier E, de Lanerolle P, Hammer JA, Hasson T, Holt JR, Hudspeth AJ, Ikebe M, Kendrick-Jones J, Korn ED, Li R, Mercer JA, Milligan RA, Mooseker MS, Ostap EM, Petit C, Pollard TD, Sellers JR, Soldati T, Titus MA.

J Cell Biol. 2001 Nov 26;155(5):703-4. Epub 2001 Nov 26.

42.

Is myosin phosphatase regulated in vivo by inhibitor-1? Evidence from inhibitor-1 knockout mice.

Carr AN, Sutliff RL, Weber CS, Allen PB, Greengard P, de Lanerolle P, Kranias EG, Paul RJ.

J Physiol. 2001 Jul 15;534(Pt. 2):357-66.

43.

Activated PAK4 regulates cell adhesion and anchorage-independent growth.

Qu J, Cammarano MS, Shi Q, Ha KC, de Lanerolle P, Minden A.

Mol Cell Biol. 2001 May;21(10):3523-33.

44.

Regulation of cyclic guanosine monophosphate-dependent protein kinase in human uterine tissues during the menstrual cycle.

Cornwell TL, Li J, Sellak H, de Lanerolle P, Rodgers WH, Miller RT, Word RA.

Biol Reprod. 2001 Mar;64(3):857-64.

PMID:
11207201
45.

A myosin I isoform in the nucleus.

Pestic-Dragovich L, Stojiljkovic L, Philimonenko AA, Nowak G, Ke Y, Settlage RE, Shabanowitz J, Hunt DF, Hozak P, de Lanerolle P.

Science. 2000 Oct 13;290(5490):337-41.

46.

Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability.

Tinsley JH, De Lanerolle P, Wilson E, Ma W, Yuan SY.

Am J Physiol Cell Physiol. 2000 Oct;279(4):C1285-9.

47.

Myosin light chain kinase plays an essential role in S. flexneri dissemination.

Rathman M, de Lanerolle P, Ohayon H, Gounon P, Sansonetti P.

J Cell Sci. 2000 Oct;113 Pt 19:3375-86.

48.

Effects of microtubules and microfilaments on [Ca(2+)](i) and contractility in a reconstituted fibroblast fiber.

Obara K, Nobe K, Nobe H, Kolodney MS, De Lanerolle P, Paul RJ.

Am J Physiol Cell Physiol. 2000 Sep;279(3):C785-96.

49.

Inhibition of myosin light chain kinase by p21-activated kinase.

Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P.

Science. 1999 Mar 26;283(5410):2083-5.

50.

Regulation of cytoskeletal mechanics and cell growth by myosin light chain phosphorylation.

Cai S, Pestic-Dragovich L, O'Donnell ME, Wang N, Ingber D, Elson E, De Lanerolle P.

Am J Physiol. 1998 Nov;275(5):C1349-56. doi: 10.1152/ajpcell.1998.275.5.C1349.

PMID:
9814984

Supplemental Content

Loading ...
Support Center